lomefloxacin has been researched along with Prostatic Hyperplasia in 3 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study was designed to evaluate two dosage regimens of a new difluoroquinolone, lomefloxacin, for prevention of postoperative bacteriuria following VLAP." | 5.07 | Lomefloxacin prophylaxis in visual laser ablation of the prostate. ( Costa, FJ, 1994) |
| "Forty four patients with benign prostatic hypertrophy treated with transurethral resection of the prostate (TUR-P) were entered in this study." | 1.29 | [Lomefloxacin concentration in human prostatic tissue following 3-day administration]. ( Hatakeyama, T; Morita, M; Suzuki, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, FJ | 1 |
| Morita, M | 1 |
| Hatakeyama, T | 1 |
| Suzuki, K | 1 |
| Leroy, A | 1 |
| Humbert, G | 1 |
| Fillastre, JP | 1 |
| Grise, P | 1 |
1 trial available for lomefloxacin and Prostatic Hyperplasia
| Article | Year |
|---|---|
Lomefloxacin prophylaxis in visual laser ablation of the prostate.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteriuria; Fluoroquinolones; Humans; Laser Therapy | 1994 |
2 other studies available for lomefloxacin and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Lomefloxacin concentration in human prostatic tissue following 3-day administration].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male | 1993 |
Penetration of lomefloxacin into human prostatic tissue.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male | 1992 |